Financial reports
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
10 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
Current reports
8-K
Other Events
19 Apr 24
8-K
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
19 Apr 24
8-K
Other Events
18 Apr 24
8-K
Bio-Path Holdings Expands Global Patent Portfolio
15 Apr 24
8-K
Entry into a Material Definitive Agreement
4 Apr 24
8-K
Bio-Path Holdings Provides 2024 Clinical and Operational Update
2 Apr 24
8-K
Other Events
27 Mar 24
8-K
Entry into a Material Definitive Agreement
26 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Mar 24
8-K
Other Events
11 Mar 24
Registration and prospectus
424B5
Prospectus supplement for primary offering
19 Apr 24
424B5
Prospectus supplement for primary offering
19 Apr 24
D
$317.93 k in options / securities to be acquired, sold $317.93 k, 1 investor
5 Apr 24
424B5
Prospectus supplement for primary offering
4 Apr 24
424B5
Prospectus supplement for primary offering
27 Mar 24
RW
Registration withdrawal request
25 Mar 24
S-1/A
IPO registration (amended)
13 Mar 24
S-1
IPO registration
8 Mar 24
RW
Registration withdrawal request
29 Feb 24
S-1/A
IPO registration (amended)
23 Jan 24
Proxies
DEFA14A
Additional proxy soliciting materials
24 Jan 24
DEFA14A
Additional proxy soliciting materials
17 Jan 24
DEF 14A
Definitive proxy
4 Jan 24
PRE 14A
Preliminary proxy
22 Dec 23
DEFA14A
Additional proxy soliciting materials
8 Dec 23
DEFA14A
Additional proxy soliciting materials
27 Oct 23
DEF 14A
Definitive proxy
27 Oct 23
DEFA14A
Additional proxy soliciting materials
28 Oct 22
DEF 14A
Definitive proxy
28 Oct 22
DEFA14A
Additional proxy soliciting materials
17 Dec 21
Other
EFFECT
Notice of effectiveness
3 Aug 23
CORRESP
Correspondence with SEC
1 Aug 23
CORRESP
Correspondence with SEC
1 Aug 23
EFFECT
Notice of effectiveness
9 Feb 23
CORRESP
Correspondence with SEC
6 Feb 23
UPLOAD
Letter from SEC
4 Jan 23
EFFECT
Notice of effectiveness
15 Jun 22
CORRESP
Correspondence with SEC
10 Jun 22
UPLOAD
Letter from SEC
2 Jun 22
EFFECT
Notice of effectiveness
6 Jun 19
Ownership
SC 13G
INTRACOASTAL CAPITAL, LLC
3 Apr 24
SC 13G
Hudson Bay Capital Management LP
2 Feb 24
4
Heath Cleaver
4 May 23
4
Paul Aubert
4 May 23
4
Aline Sherwood
4 May 23
4
DOUGLAS P MORRIS
4 May 23
4
Peter Henry Nielsen
4 May 23
4
Aline Sherwood
8 Apr 22
3
Aline Sherwood
8 Apr 22
4
DOUGLAS P MORRIS
30 Mar 22